Crispr Therapeutics shares owned by Koss-Olinger Consulting
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Koss-Olinger Consulting
from 13F filings
Historical chart of Koss-Olinger Consulting investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Koss-Olinger Consulting consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Koss-Olinger Consulting
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $746k | 16k | 47.01 |
| 2024-06-30 | $860k | 16k | 54.03 |
| 2023-09-30 | $1.1M | 25k | 45.39 |
| 2023-06-30 | $1.2M | 22k | 56.14 |
| 2023-03-31 | $972k | 22k | 45.21 |
| 2021-06-30 | $2.0M | 13k | 161.90 |
| 2021-03-31 | $1.4M | 11k | 121.87 |